Biocryst Pharmaceuticals (BCRX) Other financing activities (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) reported Other financing activities of $5.0 million for Q1 2026, up 1790.08% quarter-over-quarter from $262000.0 in Q3 2023.
Biocryst Pharmaceuticals (BCRX) Other financing activities (2011 - 2026) Analysis & Trends
Biocryst Pharmaceuticals has reported Other financing activities for 9 years, with the latest figure at $5.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (changed N/A YoY), and the FY2023 full-year result was $11.1 million, changed N/A from the prior year.
- Other financing activities for Q1 2026 stood at $5.0 million, up from $262000.0 in the prior quarter.
- The five-year high for Other financing activities was $5.0 million in Q1 2026, with the low at $262000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 1.78 Bn | 151.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.95 Mn |
| Mar 31, 2026 | 4.95 Mn |
| Sep 30, 2023 | 262,000.00 |
| Sep 30, 2023 | 262,000.00 |
| Dec 31, 2018 | -20,000.00 |
| Dec 31, 2018 | -20,000.00 |
| Sep 30, 2018 | -19,000.00 |
| Sep 30, 2018 | -19,000.00 |
| Jun 30, 2018 | -18,000.00 |
| Jun 30, 2018 | -18,000.00 |
| Mar 31, 2018 | -19,000.00 |
| Mar 31, 2018 | -19,000.00 |
| Dec 31, 2017 | -17,000.00 |
| Dec 31, 2017 | -17,000.00 |
| Dec 31, 2016 | 29,000.00 |
| Dec 31, 2016 | 29,000.00 |
| Sep 30, 2016 | 86,000.00 |
| Sep 30, 2016 | 86,000.00 |
| Jun 30, 2016 | 83,000.00 |
| Jun 30, 2016 | 83,000.00 |